Autobio Diagnostics' emergency use authorization for its Anti-SARS-CoV-2 Rapid Tests for IgM and IgG antibodies has been revoked by the FDA due to accuracy concerns.
FDA rescinds Autobio Diagnostics' COVID-19 test EUA
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.